Colon cancers frequently harbor truncating mutations to APC that yield proteins with impeded function in degrading β-catenin; or oncogenic mutations to the CTNNB1 gene that remove the destruction complex phosphorylation sites in the N-terminus of β-catenin [35]. Here, APC is linked to malignant colon neoplasm.